| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.7M | +1096.6% |
| R&D Expense | $4.6M | +219.9% |
| SG&A Expense | $15.2M | +654.8% |
| Operating Income | -$39.3M | -3252.7% |
| Interest Expense | -$177K | — |
| Pre-tax Income | -$53.3M | -943.7% |
| Income Tax | $2K | -99.6% |
| Net Income | -$53.3M | -1020.1% |
| EPS (Basic) | -$2.43 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.4M | +605.7% |
| Accounts Receivable | $205K | — |
| Inventory | $1.4M | — |
| Current Assets | $21.2M | +5550.7% |
| Total Assets | $25.2M | -85.6% |
| Current Liabilities | $4.0M | +260.7% |
| Total Liabilities | $14.8M | +81.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.8M | -3888.9% |
| Capital Expenditures | $113K | +277.8% |
| Investing Cash Flow | -$3.3M | -113.9% |
| Financing Cash Flow | $43.2M | +353.8% |
| Free Cash Flow | -$25.9M | -3729.0% |
| -298.4% |
| EPS (Diluted) | -$2.43 | -298.4% |
| Stockholders' Equity |
| $10.4M |
| +277.2% |